Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | GMAB | AMGN | GILD | VRTX | REGN |
Company | Genmab A/S ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 27.66 | 273.45 | 67.47 | 402.44 | 911.09 |
High | 27.80 | 274.35 | 67.90 | 403.88 | 915.00 |
Low | 27.51 | 267.24 | 65.32 | 393.00 | 876.75 |
Last | 27.63 | 267.87 | 65.41 | 397.55 | 891.57 |
Change | -0.84 | -5.14 | -1.67 | -3.21 | -14.97 |
% Change | -2.95% | -1.88% | -2.49% | -0.80% | -1.65% |
Volume | 163,510 | 557,784 | 4,163,511 | 286,855 | 235,115 |
20-Day Average Volume | 387,263 | 2,086,259 | 6,306,002 | 938,059 | 437,356 |
Previous Close | 28.47 | 273.01 | 67.08 | 400.76 | 906.54 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 29.29 | 270.65 | 68.70 | 402.15 | 922.32 |
20-Day Raw Stochastic | 3.62% | 27.47% | 3.63% | 11.51% | 10.73% |
20-Day Relative Strength | 38.50% | 43.92% | 29.16% | 40.67% | 34.02% |
Weighted Alpha | -32.54 | +8.53 | -23.14 | +13.60 | +10.45 |
Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 8% Buy | 8% Sell |
Previous Opinion | 88% Sell | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
Last Month's Opinion | 24% Sell | 24% Buy | 88% Sell | 56% Buy | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | -2.47% since 04/18/24 | +2.13% since 04/18/24 | -0.80% since 04/18/24 | +0.26% since 04/18/24 | -0.80% since 04/18/24 |
Low | 27.52 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 391.25 on 04/19/24 | 876.75 on 04/25/24 |
High | 29.21 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
1-Month | |||||
%Chg | -7.84% since 03/25/24 | -4.44% since 03/25/24 | -9.58% since 03/25/24 | -5.17% since 03/25/24 | -7.73% since 03/25/24 |
Low | 27.52 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
High | 31.02 on 03/26/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
3-Month | |||||
%Chg | -1.85% since 01/25/24 | -13.51% since 01/25/24 | -18.20% since 01/25/24 | -8.24% since 01/25/24 | -6.54% since 01/25/24 |
Low | 26.32 on 02/13/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 | 391.01 on 04/18/24 | 876.75 on 04/25/24 |
High | 31.88 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | -4.89% since 10/25/23 | -1.40% since 10/25/23 | -16.28% since 10/25/23 | +8.67% since 10/25/23 | +11.27% since 10/25/23 |
Low | 26.32 on 02/13/24 | 249.70 on 10/31/23 | 65.32 on 04/25/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
High | 32.89 on 11/17/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 18,825,218 | 146,436,016 | 83,519,768 | 103,580,040 | 99,503,640 |
Shares Outstanding, K | 661,230 | 536,376 | 1,245,077 | 258,459 | 109,762 |
Annual Sales | 2,392,030,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
Annual Net Income | 631,910,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
Last Quarter Sales | 674,810,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
Last Quarter Net Income | 90,250,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
60-Month Beta | 0.99 | 0.58 | 0.19 | 0.35 | 0.11 |
Per-Share Information | |||||
Most Recent Earnings | 0.36 on 02/14/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 24.20 | 14.67 | 9.97 | 30.13 | 24.14 |